Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Phase”

1,642 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,642 results

Testing effectiveness (Phase 2)Looking for participantsNCT03624244
What this trial is testing

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Who this might be right for
Low Grade Endometrial Stromal Sarcoma
Centre Leon Berard 40
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06940791
What this trial is testing

Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)

Who this might be right for
Primary Central Nervous System Lymphoma
Kyorin University 92
Large-scale testing (Phase 3)Ended earlyNCT00412217
What this trial is testing

Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 94
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)UnknownNCT03121313
What this trial is testing

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

Who this might be right for
Squamous Cell Carcinoma of Oral Cavity
Chang Gung Memorial Hospital 68
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Large-scale testing (Phase 3)Looking for participantsNCT06712472
What this trial is testing

Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer

Who this might be right for
Endometrial Cancerp53abn
Gustave Roussy, Cancer Campus, Grand Paris 554
Testing effectiveness (Phase 2)Ended earlyNCT04377087
What this trial is testing

Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sarah E Taylor 3
Testing effectiveness (Phase 2)Study completedNCT03427814
What this trial is testing

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Who this might be right for
Advanced or Inoperable Gastric Cancer
BeiGene 136
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Testing effectiveness (Phase 2)Ended earlyNCT01403246
What this trial is testing

Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 9
Testing effectiveness (Phase 2)Study completedNCT06680505
What this trial is testing

Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder

Who this might be right for
Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. 300
Large-scale testing (Phase 3)Looking for participantsNCT07363642
What this trial is testing

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

Who this might be right for
Severe Asthma
AstraZeneca 400
Post-approval studies (Phase 4)Study completedNCT00770588
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 296
Large-scale testing (Phase 3)Not Yet RecruitingNCT06512363
What this trial is testing

Ramelteon in Chinese Patients With Chronic Insomnia

Who this might be right for
Chronic Insomnia
Nanjing Chia-tai Tianqing Pharmaceutical 280
Post-approval studies (Phase 4)WithdrawnNCT04614298
What this trial is testing

Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Early research (Phase 1)Looking for participantsNCT07413042
What this trial is testing

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Who this might be right for
SCLC, Extensive Stage
Peking University Cancer Hospital & Institute 24
Next Page